iKnowMed Content Updates Copied

07/20/20262026 ContentContent releasePhysician, Clinical, Admin, Billing

July 20, 2026

The following updates were made to existing Therapeutic Interchange Management content groups:

  • Denosumab (Prolia) has been updated to include denosumab-desu Subcutaneous (60 mg/mL – Osvyrti)
  • Denosumab (Xgeva) has been updated to include denosumab-desu Subcutaneous (120 mg/1.7 mL – Jubereq)

June 5, 2026

Fosaprepitant (NK-1 Antiemetics) was added to the Therapeutic Interchange Management content groups.